Wells Fargo & Company »

Oncternal Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Oncternal Therapeutics (ONCT) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Oncternal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oncternal Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncternal Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $538 408 1.32
2024-06-30 $2.3k 300 7.60
2024-03-31 $2.9k 322 9.00

More positions owned by Wells Fargo & Company

Microsoft Corporation (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Ttl Stk (ITOT)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
JPMorgan Chase & Co. Put Option (JPM)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core Msci Eafe (IEFA)
UnitedHealth (UNH)
Broadcom (AVGO)

View all positions for Wells Fargo & Company

Top funds holding Oncternal Therapeutics

Vanguard Group
BlackRock
BlackRock
Geode Capital Management
Pasadena Private Wealth
Renaissance Technologies
Morgan Stanley
Quantum Private Wealth
Virtu Financial
Acadian Asset Management
Jpmorgan Chase & Co
Tower Research Capital
Wells Fargo & Company
North Star Investment Management
Bnp Paribas Arbitrage, Snc

View all funds holding Oncternal Therapeutics